Abstract: Due to the low specificity and sensitivity of biomarkers in sepsis diagnostics, the prognosis of sepsis patient outcomes still relies on the assessment of clinical symptoms. Inflammatory response is crucial to sepsis onset and progression; however, the significance of inflammatory response-related genes (IRRGs) in sepsis prognosis is uncertain. This study developed an IRRG-based signature for sepsis prognosis and immunological function. The Gene Expression Omnibus (GEO) database was retrieved for two sepsis microarray datasets, GSE64457 and GSE69528, followed by gene set enrichment analysis (GSEA) comparing sepsis and healthy samples. A predictive signature for IRRGs was created using least absolute shrinkage and selection operator (LASSO). To confirm the efficacy and reliability of the new prognostic signature, Cox regression, Kaplan-Meier (K-M) survival, and receiver operating characteristic (ROC) curve analyses were performed. Subsequently, we employed the GSE95233 dataset to independently validate the prognostic signature. A single-sample GSEA (ssGSEA) was conducted to quantify the immune cell enrichment score and immune-related pathway activity. We found that more gene sets were enriched in the inflammatory response in sepsis patient samples than in healthy patient samples, as determined by GSEA. The signature of nine IRRGs permitted the patients to be classified into two risk categories. Patients in the low-risk group showed significantly better 28-d survival than those in the high-risk group. ROC curve analysis corroborated the predictive capacity of the signature, with the area under the curve (AUC) for 28-d survival reaching 0.866. Meanwhile, the ssGSEA showed that the two risk groups had different immune states. The validation set and external dataset showed that the signature was clinically predictive. In conclusion, a signature consisting of nine IRRGs can be utilized to predict prognosis and influence the immunological status of sepsis patients. Thus, intervention based on these IRRGs may become a therapeutic option in the future.

构建和验证与脓毒症预后相关的新的炎症反应相关基因标记

[1]Andaluz-OjedaD, BobilloF, IglesiasV, et al., 2012. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine, 57(3):332-336.

[2]BarrettT, WilhiteSE, LedouxP, et al., 2013. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res, 41(D1):D991-D995.

[3]BauerJW, BilgicH, BaechlerEC, 2009. Gene-expression profiling in rheumatic disease: tools and therapeutic potential. Nat Rev Rheumatol, 5(5):257-265.

[4]BosmannM, WardPA, 2013. The inflammatory response in sepsis. Trends Immunol, 34(3):129-136.

[5]BourasM, AsehnouneK, RoquillyA, 2018. Contribution of dendritic cell responses to sepsis-induced immunosuppression and to susceptibility to secondary pneumonia. Front Immunol, 9:2590.

[6]CuocoloR, CarusoM, PerilloT, et al., 2020. Machine learning in oncology: a clinical appraisal. Cancer Lett, 481:55-62.

[7]Darash-YahanaM, GillespieJW, HewittSM, et al., 2009. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS ONE, 4(8):e6695.

[8]DelanoMJ, WardPA, 2016. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev, 274(1):330-353.

[9]DemaretJ, VenetF, FriggeriA, et al., 2015. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol, 98(6):1081-1090.

[10]DengZL, ZhouDZ, CaoSJ, et al., 2022. Development and validation of an inflammatory response-related gene signature for predicting the prognosis of pancreatic adenocarcinoma. Inflammation, 45(4):1732-1751.

[11]EvansL, RhodesA, AlhazzaniW, et al., 2021. Executive summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021. Crit Care Med, 49(11):1974-1982.

[12]FengAL, MaWL, FarajR, et al., 2021. Identification of S1PR3 gene signature involved in survival of sepsis patients. BMC Med Genomics, 14:43.

[13]FleischmannC, ScheragA, AdhikariNKJ, et al., 2016. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med, 193(3):259-272.

[14]Fleischmann-StruzekC, MellhammarL, RoseN, et al., 2020. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med, 46(8):1552-1562.

[15]GottsJE, MatthayMA, 2016. Sepsis: pathophysiology and clinical management. BMJ, 353:i1585.

[16]HannaMOF, AbdelhameedAM, Abou-ElallaAA, et al., 2019. Neutrophil and monocyte receptor expression in patients with sepsis: implications for diagnosis and prognosis of sepsis. Pathog Dis, 77(6):ftz055.

[17]HänzelmannS, CasteloR, GuinneyJ, 2013. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics, 14:7.

[18]HeWX, XiaoK, FangM, et al., 2021. Immune cell number, phenotype, and function in the elderly with sepsis. Aging Dis, 12(1):277-296.

[19]HelmkeA, NordlohneJ, BalzerMS, et al., 2019. CX3CL1‍‒CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis. Kidney Int, 95(6):1405-1417.

[20]HotchkissRS, MonneretG, PayenD, 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol, 13(12):862-874.

[21]ItagakiK, KaczmarekE, KwonWY, et al., 2020. Formyl peptide receptor-1 blockade prevents receptor regulation by mitochondrial danger-associated molecular patterns and preserves neutrophil function after trauma. Crit Care Med, 48(2):e123-e132.

[22]JensenIJ, WinbornCS, FosdickMG, et al., 2018. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog, 14(10):e1007405.

[23]JuAJ, TangJZ, ChenSH, et al., 2021. Pyroptosis-related gene signatures can robustly diagnose skin cutaneous melanoma and predict the prognosis. Front Oncol, 11:709077.

[24]KolaczkowskaE, KubesP, 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol, 13(3):159-175.

[25]KorbeckiJ, SimińskaD, KojderK, et al., 2020. Fractalkine/CX3CL1 in neoplastic processes. Int J Mol Sci, 21(10):3723.

[26]KriplaniA, PanditS, ChawlaA, et al., 2022. Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL). Urolithiasis, 50(3):341-348.

[27]LevyMM, EvansLE, RhodesA, 2018. The surviving sepsis campaign bundle: 2018 update. Crit Care Med, 46(6):997-1000.

[28]LiberzonA, BirgerC, ThorvaldsdóttirH, et al., 2015. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst, 1(6):417-425.

[29]LuJQ, LiuJY, LiA, 2022. Roles of neutrophil reactive oxygen species (ROS) generation in organ function impairment in sepsis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(6):437-450.

[30]MarkwartR, SaitoH, HarderT, et al., 2020. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med, 46(8):1536-1551.

[31]MiyataK, YotsumotoF, NamSO, et al., 2012. Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer. Anticancer Res, 32(6):2347-2352.

[32]NiCM, LingBY, XuX, et al., 2020. CX3CR1 contributes to streptozotocin-induced mechanical allodynia in the mouse spinal cord. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(2):166-171.

[33]PanklaR, BuddhisaS, BerryM, et al., 2009. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol, 10(11):R127.

[34]PattenM, BünemannJ, ThomaB, et al., 2002. Endotoxin induces desensitization of cardiac endothelin-1 receptor signaling by increased expression of RGS4 and RGS16. Cardiovasc Res, 53(1):156-164.

[35]RaspéC, HöcherlK, RathS, et al., 2013. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis. Cytokine, 61(1):97-103.

[36]ReinhartK, BauerM, RiedemannNC, et al., 2012. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev, 25(4):609-634.

[37]RheeC, DantesR, EpsteinL, et al., 2017. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA, 318(13):1241-1249.

[38]RhodesA, EvansLE, AlhazzaniW, et al., 2017. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med, 43(3):304-377.

[39]RichJT, NeelyJG, PanielloRC, et al., 2010. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg, 143(3):331-336.

[40]RobinX, TurckN, HainardA, et al., 2011. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12:77.

[41]RuanL, ChenGY, LiuZ, et al., 2018. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care, 22:316.

[42]SchlattererK, BeckC, SchoppmeierU, et al., 2021a. Acetate sensing by GPR43 alarms neutrophils and protects from severe sepsis. Commun Biol, 4:928.

[43]SchlattererK, PeschelA, KretschmerD, 2021b. Short-chain fatty acid and FFAR2 activation—a new option for treating infections? Front Cell Infect Microbiol, 11:785833.

[44]SciclunaBP, KlouwenbergPMCK, van VughtLA, et al., 2015. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med, 192(7):826-835.

[45]SilwalP, KimJK, KimYJ, et al., 2020. Mitochondrial reactive oxygen species: double-edged weapon in host defense and pathological inflammation during infection. Front Immunol, 11:1649.

[46]SingerM, DeutschmanCS, SeymourCW, et al., 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 315(8):801-810.

[47]SubramanianA, TamayoP, MoothaVK, et al., 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 102(43):15545-15550.

[48]van der PollT, van de VeerdonkFL, SciclunaBP, et al., 2017. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol, 17(7):407-420.

[49]VenetF, MonneretG, 2018. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol, 14(2):121-137.

[50]VenetF, SchillingJ, CazalisMA, et al., 2017. Modulation of LILRB2 protein and mRNA expressions in septic shock patients and after ex vivo lipopolysaccharide stimulation. Hum Immunol, 78(5-6):441-450.

[51]WatanabeN, SuzukiY, InokuchiS, et al., 2016. Sepsis induces incomplete M2 phenotype polarization in peritoneal exudate cells in mice. J Intensive Care, 4:6.

[52]WedepohlS, Beceren-BraunF, RieseS, et al., 2012. L-Selectin‒a dynamic regulator of leukocyte migration. Eur J Cell Biol, 91(4):257-264.

[53]WintersBD, EberleinM, LeungJ, et al., 2010. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med, 38(5):1276-1283.

[54]XiaoZJ, LiJY, YuQ, et al., 2021. An inflammatory response related gene signature associated with survival outcome and gemcitabine response in patients with pancreatic ductal adenocarcinoma. Front Pharmacol, 12:778294.

[55]XuF, ZhouFC, 2020. Inhibition of microRNA-92a ameliorates lipopolysaccharide-induced endothelial barrier dysfunction by targeting ITGA5 through the PI3K/Akt signaling pathway in human pulmonary microvascular endothelial cells. Int Immunopharmacol, 78:106060.

[56]ZhongWW, WangDJ, YaoB, et al., 2021. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(8):664-681.

[57]ZouWJ, ChenL, MaoWW, et al., 2021. Identification of inflammatory response-related gene signature associated with immune status and prognosis of lung adenocarcinoma. Front Bioeng Biotechnol, 9:772206.